In 25+ years of working up patients for surgery I have NEVER had...

First 58 Last

Share
Profile

Follow
Enduranz

4 Posts.

1

15/02/19

12:22

Post #: 37448878
Share

Originally posted by Teddyward: ↑

The comments that will gradually accumulate on this cut and past job will be interesting to see.

The ones notes so far are

No one has taken them over - yep there has been a very pen register and no one nibbled.
Patents
Market protection
Lack of world market penetration
Shares on issue
market Cap
Fact it is OTC- Nasdaq listing needs restructure
Animal bases enzyme- counts out some religious groups and also ethical patients
Competitors

No comments on management and the rewards they will and have given themselves
No comments on the actual market size they are actually approved for and the % of that market they are economical in .
No comment on short shelf life

I'll leave it at that for the minute but years of discussion on these threads has fleshed a lot of it out

Be interesting to see if any of the posters actually go into a lot of depth .

The comments on other USA forums are beyond belief with mostly pure pumping claims without any reality especially in regards to market valuations and what margin and turnover AVH would have to achieve to get anywhere near sustainable claimed profit. It may be a newly approved device but it is a old company and old news .

If someone wants to help the posters over there they might want to link directly to information from trials and other studies as they show many of the issues.

So the preeminent USA millitary hospital that treats burns has only 1200 patients a year . Yep they take all the peopel from germany. Another 4000 from general public and militarily non serving. Shows that via discipline , clothing, supervision that the military is a employer who is out to minimize injury to its employees. That is a long way from the numbers spruiked and that number includes the most savage periods in iraq etc.

People just need to fact check and also realize that NASDAQ is not a cure-all. It won't get the sustained valuation others predict and unless they get support usually by issue a crapload of shares they will be a plaything . Interesting to see how fast they burn the existing 40 mill and how many trials they can get running as they need more arms to their approvals to be a growing business without long stagnant periods where management get paid and rewarded and shareholders sit and watch IMO.

Sellers - just remember how many shares on issue and that those large holders will know when a new raising is happening so they will let existing shares go and top up on a cheaper issue . Thats the game and the only way except for performance that they will keep large holders on board unless it becomes a corporate action target.

Expand

In 25+ years of working up patients for surgery I have NEVER had a patient ask me about "Human Enzymes". There are groups that absolutely refuse blood and blood products yet a surprising number of those will accept albumin, a colloid containing human serum protein, in a life threatening situation. I think you can remove that "note" from your list. It's a non-issue.

AVH Price at posting: 14.8¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

REA

UK-based Rightmove knocks back REA Group's acquisition proposal

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

There are more pages in this discussion • 2 more messages in this thread...

First 58 Last

Add AVH (ASX) to my watchlist

(20min delay)
Last $2.78		Change 0.110(4.12%)		Mkt cap ! $195.7M

Open	High	Low	Value	Volume
$2.77	$2.82	$2.74	$999.8K	359.6K

Buyers (Bids)

No.	Vol.	Price($)
2	5419	$2.76

Sellers (Offers)

Price($)	Vol.	No.
$2.79	10000	1

View Market Depth

No.	Vol.	Price($)
2	5419	2.760
2	15000	2.740
1	5000	2.730
1	2500	2.720
1	5000	2.710

Price($)	Vol.	No.
2.790	10000	1
2.800	5705	4
2.810	23225	4
2.840	419	1
2.850	1495	3

Last trade - 16.10pm 11/09/2024 (20 minute delay)

AVH (ASX) Chart

In 25+ years of working up patients for surgery I have NEVER had...

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

UK-based Rightmove knocks back REA Group's acquisition proposal

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

In 25+ years of working up patients for surgery I have NEVER had...

Top Stories

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

UK-based Rightmove knocks back REA Group's acquisition proposal

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News